Microbot Medical stock gains as investors await November 6 results
Published on 09/20/2026 at 21:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Microbot Medical stock (ISIN US5950101098) last traded at USD 1.36 on September 20, 2026, with a market capitalization near USD 17 million and a 52-week range of USD 1.35 to USD 3.74. The same snapshot shows the shares were unchanged on the day, with a session range of USD 1.35 to USD 1.43.
November 6 is the next date
According to Investing.com, Microbot Medical's next earnings report is scheduled for November 6, 2026. The same page says the stock's latest closing price was USD 1.36 and that after-hours trading put the shares at USD 1.378, down USD 0.018 or 1.320 percent.
Revenue doubled sequentially
Investing.com also says Microbot Medical reported second-quarter 2026 revenue on August 18, 2026, and that revenue was more than twice the prior quarter's level. That makes the most recent reported quarter the key operating reference, while the stock still trades close to its 52-week low of USD 1.35.
The same stock page lists the 52-week high at USD 3.74, which leaves the latest close more than 63 percent below that peak. For investors, that gap matters more than the unchanged daily move.
Stock near the lows
Microbot Medical stock traded at USD 1.36 on September 20, 2026, on Nasdaq. Market cap was about USD 17 million at the same as-of point, and the shares remained within 1 cent of the 52-week low.
Microbot Medical stock data
- Company: Microbot Medical Inc.
- ISIN: US5950101098
- Ticker: MBOT
- Trading venue: Nasdaq
- Price (as of September 20, 2026): USD 1.36
- Market capitalization: about USD 17 million (as of September 18, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: not in a major US benchmark index
- Next earnings date: November 6, 2026
